GWCM
TMO icon

Godshalk Welsh Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Godshalk Welsh Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$13K – 228
2014
Q4 		$13K Buy
+100
New +$12.2K 0.01% 256

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Godshalk Welsh Capital Management's TMO Position: Q1 2015 in Review

Godshalk Welsh Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2015, closing a stake of 100 shares — an estimated $13K sold.

Godshalk Welsh Capital Management first reported a position in TMO in Q4 2014 and held it in 1 quarter. The position peaked at $13K in Q4 2014. 964 funds tracked by Wall St. Rank hold TMO as of Q1 2015.

  • Godshalk Welsh Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2015 after selling out during the quarter.
  • Godshalk Welsh Capital Management sold 100 Thermo Fisher Scientific shares in Q1 2015, an estimated $13K.
  • Godshalk Welsh Capital Management first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 1 quarter.
  • Godshalk Welsh Capital Management's Thermo Fisher Scientific position peaked at $13K in Q4 2014.
  • 964 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2015.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2015, filed 12 May 2015.